| Financial Year |
March 31 2023 |
| Monetary Funds |
157,234,095.72 |
| Held-for-trading Financial Assets |
880,107,519.53 |
| Notes Receivable |
2,624,271.68 |
| Accounts Receivable |
814,542,619.18 |
| Advances to Suppliers |
76,492,486.31 |
| Other Receivables |
17,659,092.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
246,080,947.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
791,816,098.16 |
| Total Current Assets |
3,019,687,653.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
97,981,813.46 |
| Long-term Equity Investment |
14,893,273.12 |
| Investment Properties |
-- |
| Fixed Assetes |
168,875,400.66 |
| Under-construction Projects |
159,385,521.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,223,250.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
428,547.24 |
| Deferred Income Tax Assets |
30,906,406.87 |
| Other Non-Current Assets |
38,945,891.98 |
| Sub-Total of Non-Current Assets |
580,460,523.48 |
| Total Assets |
3,600,148,177.17 |
| Short-Term Loans |
215,204,050.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
107,800,000.00 |
| Accounts Payable |
347,395,730.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,282,795.35 |
| Taxes Payable |
61,535,613.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,008,799.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
104,399,809.60 |
| Other Current Liabilities |
2,283,253.02 |
| Sub-Total of Current Liabilities |
923,499,808.26 |
| Long-term Loans |
16,775,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,677,859.84 |
| Deferred Income Tax Liabilities |
1,824,463.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
57,064,430.17 |
| Total Liabilities |
980,564,238.43 |
| Paid-In Capital(Or Share Stock) |
167,996,636.00 |
| Capital Surplus |
1,839,888,959.78 |
| Surplus Reserve |
83,998,318.00 |
| LESS:Treasury Stock |
147,003,685.05 |
| Undistributed Profits |
656,156,557.80 |
| Minority Stockholder's Interest |
18,547,152.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,601,036,786.53 |
| Owner's Equity（Stockholder's Equity） |
2,619,583,938.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,600,148,177.17 |
